Maximus (MMS)
(Delayed Data from NYSE)
$90.10 USD
+1.55 (1.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $90.08 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.10 USD
+1.55 (1.75%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $90.08 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth F Momentum B VGM
Zacks News
DocuSign (DOCU) Appreciates 8% in Six Months: Here's Why
by Zacks Equity Research
DocuSign (DOCU) is benefiting from the continued demand for its main product, eSignatures.
Reasons for Trane Technologies' (TT) 12.5% Gain in 6 Months
by Zacks Equity Research
Trane Technologies' (TT) consistent earnings beat coupled with growth in the top and the bottom lines attract investors' attention.
Republic Services (RSG) Appreciates 6% in 3 Months: Here's How
by Zacks Equity Research
Operational efficiency and investor-friendly steps boost Republic Services (RSG) shares.
Waste Connections (WCN) Gains 4.2% in 3 Months: Here's How
by Zacks Equity Research
Waste Connections (WCN) is benefiting from acquisitions, operating efficiency and an increase in prices charged to customers.
Waste Management (WM) Gains 6.3% in Past 3 Months: Here's How
by Zacks Equity Research
Waste Management (WM) relies on organic growth and strong solid waste business performance.
Why Should You Start Adding Maximus (MMS) to Your Portfolio?
by Zacks Equity Research
Maximus (MMS), with the benefits of regular dividend payments, strategic acquisitions and being a bankable partner of the government, qualifies as a good investment opportunity.
Why Is Maximus (MMS) Down 5.6% Since Last Earnings Report?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Maximus (MMS) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Maximus (MMS) have what it takes to be a top stock pick for momentum investors? Let's find out.
MAXIMUS (MMS) Stock Up 11% Since Q1 Earnings & Revenue Beat
by Zacks Equity Research
MAXIMUS' (MMS) first-quarter fiscal 2023 earnings decline year over year while revenues grow.
Maximus (MMS) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 18.99% and 8.43%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Maximus (MMS) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Maximus's (MMS) first-quarter fiscal 2023 earnings are expected to have decreased year over year.
Earnings Preview: Maximus (MMS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Booz Allen Hamilton (BAH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Booz Allen (BAH) delivered earnings and revenue surprises of 4.90% and 4.01%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Is Maximus (MMS) Up 1.4% Since Last Earnings Report?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Stock Up 20% Since Q4 Earnings & Revenue Beat
by Zacks Equity Research
MAXIMUS (MMS) fourth-quarter fiscal 2022 earnings and revenues surged year over year.
Maximus (MMS) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 37.25% and 7.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
IBEX Limited (IBEX) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
IBEX Limited (IBEX) delivered earnings and revenue surprises of 17.24% and 1.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
ICF International (ICFI) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
ICF (ICFI) delivered earnings and revenue surprises of 11.81% and 0.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Investors Should Retain Maximus (MMS) Stock Now
by Zacks Equity Research
Solid track record of dividend payments boosts Maximus (MMS).
Maximus (MMS) Down 5.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Misses on Q3 Earnings, Trims '22 EPS View
by Zacks Equity Research
MAXIMUS's (MMS) third-quarter 2022 earnings and revenues decline year over year.
Maximus (MMS) Misses Q3 Earnings Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of -20.41% and 3.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Booz Allen Hamilton (BAH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Booz Allen (BAH) delivered earnings and revenue surprises of 6.60% and 2.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Retain Maximus (MMS) Stock in Your Portfolio For Now
by Zacks Equity Research
With more than 40 years of experience, Maximus (MMS) has grown to be a leading operator of government health and human services programs globally.
Maximus (MMS) Down 5.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.